Roche announced the introduction of its innovative Chest Pain Triage algorithm as part of the navify Algorithm Suite. This groundbreaking algorithm is designed to more quickly and accurately… read more.
Air pollution across the UK dropped between 2015 and 2024, but dangerous levels are still reached too often, shows new research published today (Tuesday, 15 July) in Environmental Science:… read more.
Obesity and type 2 diabetes in adolescence can interfere with bone development, potentially increasing the risk of fractures and osteoporosis later in life, according to a study being… read more.
Merck Inc., (known as MSD outside of the United States and Canada), announced the FDA has accepted for priority review a supplemental new drug application (sNDA) seeking approval… read more.
Women diagnosed with premenstrual symptoms have a slightly increased risk of developing cardiovascular disease later in life. This is shown by a new study from Karolinska Institutet published… read more.
Junk food firms have more than 90 current sponsorship deals within top UK sports amid growing concerns over their impact on public health, finds an investigation published by The… read more.
Johnson & Johnson MedTech, a leader in neurovascular care, announced today its upcoming data presentations and onsite activities at the 2025 Society of NeuroInterventional Surgery (SNIS) 22nd Annual Meeting &… read more.
Neurocrine Biosciences, Inc. announced the release of findings from a new survey conducted by The Harris Poll highlighting the profound negative impact of tardive dyskinesia on patients and… read more.
The three most common reasons schools called emergency medical services (EMS) were for neurological crises such as seizures, psychiatric conditions or substance abuse, and trauma related injuries, according… read more.
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in… read more.
Celltrion announced that the FDA has approved Avtozma (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and subcutaneous (SC) formulation as a biosimilar to Actemra. Avtozma is indicated for… read more.
A landmark 30-year study of over four million women in England has revealed that women with endometriosis-associated infertility are significantly more likely to become pregnant compared to those… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
